Basic Information
SAT is redefining the treatment of heart valve disease. As a world first, we are able to offer cost-effective and durable transcatheter aortic valve solutions for patients with rheumatic heart disease (RHD) and degenerative heart disease (DHD) in both developed and emerging economies.
Strait Access Technologies
South Africa
15~50 people
January 01, 2012
--
Enterprise Profile
Industrial Sector
Concept
Application Scenarios